Kwenti Tebit Emmanuel, Njunda Longdoh Anna, Tsamul Beltine, Nsagha Shey Dickson, Assob Nguedia Jules-Clement, Tufon Kukwah Anthony, Meriki Dilonga Henry, Orock Enow George
Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, P.B. 63, Buea, Southwest Region, Cameroon.
Department of Public Health and Hygiene, Faculty of Health Sciences, University of Buea, P.B. 63, Buea, Southwest Region, Cameroon.
Infect Dis Poverty. 2017 Aug 1;6(1):103. doi: 10.1186/s40249-017-0314-2.
In malaria endemic areas, infected blood donors serve as a source of infection to blood recipients, which may adversely affect their prognosis. This necessitates the proper screening of blood to be used for transfusion in these areas. The purpose of this study was to determine the prevalence of malaria parasitaemia in blood donors in Buea, Cameroon, and to evaluate the performance of a rapid diagnostic test (RDT), a malaria antibody enzyme-linked immunosorbent assay (ELISA), and a Plasmodium lactate dehydrogenase (pLDH) ELISA in the detection of asymptomatic malaria parasitaemia in the target population.
In a prospective study conducted between September 2015 and June 2016, 1 240 potential blood donors were enrolled. The donors were screened for malaria parasites using Giemsa microscopy (GM) and a RDT. A sub-sample of 184 samples, comprising 88 positive and 96 negative samples, were selected for the evaluation of the pLDH ELISA and the antibody ELISA. The chi-square test and correlation analysis were performed as part of the statistical analyses. The statistical significance cut-off was set at P < 0.05.
The prevalence of malaria parasitaemia in this study was found to be 8.1% (95% CI: 6.6 - 9.7). The prevalence was not observed to be dependent on the age or sex of the participants. The RDT had a sensitivity (88.0%), specificity (99.1%), and negative predictive value (99.0%) higher than the ELISAs. The performance of the pLDH ELISA, which demonstrated the highest positive predictive value (91.6%), was generally comparable to the RDT. The sensitivity was lowest with the antibody ELISA (69.9%), which also demonstrated the highest false positive and false negative rates. The detection threshold for the pLDH (three parasites/μl) was lower compared to the RDT (50 - 60 parasites/μl). Non-significant positive correlations were observed between the parasite density and the pLDH titers and malaria antibody titers.
Overall, the RDT and the pLDH ELISA demonstrated a perfectly correlated agreement with GM, meanwhile the antibody ELISA demonstrated a substantially correlated agreement with GM. The pLDH is therefore recommended for mass screening of blood (to detect malaria parasitaemia) for transfusions in the study area. However, where this is not feasible, an RDT will suffice.
在疟疾流行地区,受感染的献血者会成为受血者的感染源,这可能对受血者的预后产生不利影响。因此,在这些地区需要对用于输血的血液进行适当筛查。本研究的目的是确定喀麦隆布埃亚地区献血者中疟疾寄生虫血症的患病率,并评估快速诊断试验(RDT)、疟疾抗体酶联免疫吸附测定(ELISA)和疟原虫乳酸脱氢酶(pLDH)ELISA在检测目标人群无症状疟疾寄生虫血症方面的性能。
在2015年9月至2016年6月进行的一项前瞻性研究中,招募了1240名潜在献血者。使用吉姆萨显微镜检查(GM)和RDT对献血者进行疟原虫筛查。从184份样本中选取一个子样本,包括88份阳性样本和96份阴性样本,用于评估pLDH ELISA和抗体ELISA。作为统计分析的一部分,进行了卡方检验和相关性分析。统计学显著性临界值设定为P < 0.05。
本研究中疟疾寄生虫血症的患病率为8.1%(95%CI:6.6 - 9.7)。未观察到患病率取决于参与者的年龄或性别。RDT的灵敏度(88.0%)、特异性(99.1%)和阴性预测值(99.0%)高于ELISA。pLDH ELISA的性能显示出最高的阳性预测值(91.6%),总体上与RDT相当。抗体ELISA的灵敏度最低(69.9%),其假阳性和假阴性率也最高。与RDT(50 - 60个寄生虫/微升)相比,pLDH的检测阈值较低(三个寄生虫/微升)。在寄生虫密度与pLDH滴度和疟疾抗体滴度之间观察到无显著的正相关。
总体而言,RDT和pLDH ELISA与GM显示出完全相关的一致性,而抗体ELISA与GM显示出基本相关的一致性。因此,建议在研究地区使用pLDH进行大规模血液筛查(以检测疟疾寄生虫血症)用于输血。然而,在不可行的情况下,RDT也足够了。